In a new draft recommendation, the US Preventive Services Task Force USPSTF has reaffirmed its support for chemoprevention with tamoxifen multiple brands and raloxifene Evista, Lilly for women at increased risk for breast cancer and has added aromatase inhibitors AIs to its recommendation lasix iv dose WCs from C57BL 6 strain and USVs from C57BL 6 and F2 hybrid of C57BL 6 and FVB strain; used in Fig